Raised $200M · Jul 14, 2026announcement ↗
Miles Wang's unnamed startup
Backed by
Biotechnull
What they do
Miles Wang’s unnamed startup is developing AI models for drug discovery. The company’s intended users are likely pharmaceutical and biotechnology researchers, though its specific products and customer model have not been disclosed.
Hiring outlook
If the reported $200 million financing is accurate, the company may prioritize recruiting machine-learning researchers, computational biologists, drug-discovery scientists, and engineering leaders, along with infrastructure and operations staff. Because the financing stage and launch status are unknown, the timing and scope of hiring are unclear.
Open roles
Pre-flood window open
Nothing posted yet since the raise, which is exactly when a direct, well-aimed email to a founder beats every job portal. When the postings go up, so does the competition.
Get founders like this to reach you →